Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T16:25:05.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T05:50:25.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor UI/metadata change with no impact on study details.
    Difference
    0.1%
    Check dated 2026-02-13T17:26:55.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. No changes to study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-02-06T11:27:12.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0. This is a minor template/version update that does not affect study details.
    Difference
    0.1%
    Check dated 2026-02-05T11:20:45.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    Added a Show glossary control and updated page metadata to Revision: v3.4.0. Removed older labels such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T06:28:21.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.